Fluvoxamine may reverse the decrease in filtering capacity that occurs in acute kidney injury by increasing IL-10 and ACE expressions and preserving AQ-2, AQ-4, CL-5, and ZO-1 expressions
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-03844-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Nasif Fatih Karakuyu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmacology, Suleyman Demirel University, Isparta, Turkey. fatihkarakuyu@sdu.edu.tr. Hauptthemen laut MEDLINE: Acute Kidney Injury, Fluvoxamine, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Projects Coordination Unit of Suleyman Demirel University, Suleyman Demirel University.
Abstract (Originalsprache)
The kidneys have a regulatory role in many diseases with their diuresis function and capacity to maintain electrolyte balance. In case of extensive damage, the kidney’s filtration capacity is impaired and cannot fulfill its functions. Fluvoxamine (FLV), an antidepressant agent, has antioxidant and anti-inflammatory effects. This study aimed to investigate the protective effects of FLV against renal tissue damage in the lipopolysaccharide (LPS) induced systemic inflammation model. Thirty-two Wistar Albino rats were divided into four equal groups: control, LPS, LPS + FLV, and FLV alone. Six hours after LPS administration, rats were sacrificed and kidney tissues were removed. Histopathological examination of kidney tissues, immunohistochemical expression of the ACE-1, Cas-9, and interleukin-10 (IL-10), as well as spectrophotometric assessment of total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), urea, creatinine levels, and zonulin-1 (ZO-1), claudin-5 (CL-5), aquaporins 2 and 4 (AQ-2, AQ-4) were evaluated. TOS, OSI, urea, creatinine levels, and Cas-9 expressions were significantly increased, and TAS levels, ACE-1, IL-10, AQ-2, AQ-4, ZO-1, and CL-5 expressions significantly decreased in the LPS group compared with the control group. In addition, marked hyperemia, slight-to-moderate hemorrhages, and degeneration of the tubule epithelial cells were observed in kidney sections in the LPS group, in addition to the inflammatory cell infiltrations. FLV treatment significantly improved all these findings. FLV treatment ameliorates renal tissues against inflammatory scenes and protects renal function by enhancing IL-10 and ACE-1 expressions and preserving AQ-2, AQ-4, CL-5, and ZO-1 expressions. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmacology, Suleyman Demirel University, Isparta, Turkey. fatihkarakuyu@sdu.edu.tr.
- Health Research and Application Center, Suleyman Demirel University Research and Application Hospital, Isparta, Turkey.
- Faculty of Medicine, Department of Pharmacology, Suleyman Demirel University, Isparta, Turkey.
- Faculty of Veterinary Medicine, Department of Pathology, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
- Institute of Science, Department of Bioengineering, Suleyman Demirel University, Isparta, Turkey.
- Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
ORCID-Profile: Nasif Fatih Karakuyu, Tugce Camlica, Halil Asci, Adem Milletsever, Arzu Ulusoy, Fatih Mehmet Gonuler, Atila Altuntas
Förderung
- Scientific Research Projects Coordination Unit of Suleyman Demirel University
- Suleyman Demirel University
Zitieren
APA
Karakuyu, N. F., Camlica, T., Asci, H., Milletsever, A., Ulusoy, A., Gonuler, F. M., & Altuntas, A. (2025). Fluvoxamine may reverse the decrease in filtering capacity that occurs in acute kidney injury by increasing IL-10 and ACE expressions and preserving AQ-2, AQ-4, CL-5, and ZO-1 expressions. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03844-2
Vancouver
Karakuyu NF, Camlica T, Asci H, Milletsever A, Ulusoy A, Gonuler FM, et al. Fluvoxamine may reverse the decrease in filtering capacity that occurs in acute kidney injury by increasing IL-10 and ACE expressions and preserving AQ-2, AQ-4, CL-5, and ZO-1 expressions. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03844-2
BibTeX
@article{Karakuyu2025,
author = {Karakuyu, Nasif Fatih and Camlica, Tugce and Asci, Halil and Milletsever, Adem and Ulusoy, Arzu and Gonuler, Fatih Mehmet and Altuntas, Atila},
title = {Fluvoxamine may reverse the decrease in filtering capacity that occurs in acute kidney injury by increasing IL-10 and ACE expressions and preserving AQ-2, AQ-4, CL-5, and ZO-1 expressions},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-03844-2}
}
EUVIMED